Cargando…
Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies
Treatment of myelofibrosis (MF), a BCR-ABL–negative myeloproliferative neoplasm, is challenging. The only current potentially curative option, allogeneic hematopoietic stem cell transplant, is recommended for few patients. The remaining patients are treated with palliative therapies to manage MF-rel...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975838/ https://www.ncbi.nlm.nih.gov/pubmed/24598114 http://dx.doi.org/10.1186/1756-8722-7-18 |